Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|January 18, 2023
CBX5 loss drives EGFR inhibitor resistance and results in therapeutically actionable vulnerabilities in lung cancerSuresh Bugide, Yvonne J K Edwards, Romi Gupta, et al.Journal of Virology|October 3, 2008
Structural determinant of human La protein critical for internal initiation of translation of hepatitis C virus RNATanmoy Mondal, Upasana Ray, Asit Kumar Manna, et al.Cell Death & Disease|July 21, 2023
ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPEPraveen Guruvaiah, Suresh Chava, Chiao-Wang Sun, et al.Proceedings of the National Academy of Sciences of the United States of America|February 21, 2019
Loss of BOP1 confers resistance to BRAF kinase inhibitors in melanoma by activating MAP kinase pathwayRomi Gupta, Suresh Bugide, Biao Wang, et al.Journal of Clinical Microbiology|March 7, 2006
Analysis of mutations within the 5' untranslated region, interferon sensitivity region, and PePHD region as a function of response to interferon therapy in hepatitis C virus-infected patients in IndiaRomi Gupta, Murugan Subramani, Mohammed N Khaja, et al.Cell Death & Disease|June 26, 2024
ASAH1 facilitates TNBC by DUSP5 suppression-driven activation of MAP kinase pathway and represents a therapeutic vulnerabilityKiran Kumar Reddi, Suresh Chava, Siva Chander Chabattula, et al.EMBO Reports|December 2, 2025
ATAD2 drives melanoma growth and progression and inhibits ferroptosisAshok Mari, Kevin Graciano, Raj Kumar, et al.Oncogene|March 6, 2021
PSPH promotes melanoma growth and metastasis by metabolic deregulation-mediated transcriptional activation of NR4A1Vipin Rawat, Parmanand Malvi, Deborah Della Manna, et al.Oncogenesis|August 30, 2020
LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1Parmanand Malvi, Radoslav Janostiak, Suresh Chava, et al.Cell Reports. Medicine|September 17, 2025
PDE7A inhibition suppresses triple-negative breast cancer by attenuating de novo pyrimidine biosynthesisParmanand Malvi, Suresh Bugide, Roshan Dutta, et al.Pageof 5